Sign in →

Test Code AB Hepatitis B Surface Antibody (Qualitative & Quantitative)

Useful For

To aid in the diagnosis of hepatitis B. Determining the phase of a hepatitis B infection. Determination of immune status.

Synonyms/Keywords

HBsAb, Hepatitis Post-vaccine testing, Anti-HBs

Specimen Requirements

Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No Serum Serum Separator Tube (SST) Red Top Tube (RTT) 1 mL 0.5 mL 0.3 mL

Collection/Processing Instructions

Separate serum from the blood within 60 minutes of venipuncture and transport in an aliquot tube. Specimen must be free of particulate matter including fibrin.


Regional/Outreach sites: Please send samples to Marshfield frozen. 

High doses of exogenous biotin (also termed Vitamin B7, Vitamin H or Coenzyme R) may interfere with this assay. It is recommended that patients refrain from consuming any multivitamin or supplement containing biotin for at least 72 hours prior to collection of a blood sample. 

Specimen Stability Information

Specimen Type Temperature Time
Serum Ambient <8 hours
Refrigerate <48 hours
Frozen at -20 C 6 months
Frozen at -70 C >6 months

Rejection Criteria

Grossly hemolyzed
Grossly icteric
Specimens containing precipitate
Cadaver specimens
Heat-inactivated specimens
Body fluids other than serum

Test Information

Hepatitis B is a viral illness that is transmitted through blood and other body fluids. Both acute and chronic stages occur, with the frequency of progression to chronicity declining with age at time of infection. Chronic hepatitis B often leads to cirrhosis and hepatocellular carcinoma. Hepatitis B is a vaccine-preventable disease.

 

Limitations:

  • The results determined by different assays from different manufacturers can vary due to differences in assay specificities and cannot be used interchangeably.
  • Assay performance characteristics have not been established in pregnant women or in populations of immunocompromised or immunosuppressed patients.
  • This assay does not differentiate between a vaccine-induced immune response and an immune response induced by infection with HBV. To determine if the anti-HBs response is due to vaccine or HBV infection, a Total anti-Hepatitis B Core assay may be performed.
  • This assay is not intended for use in screening blood or plasma donors.
  • A positive anti-HBs result does not exclude co-infection by another hepatitis virus.

Interferences

Heterophilic antibodies in human serum can react with the immunoglobulins included in the assay components causing interference with immunoassay.

Interpretations

The presence of hepatitis B surface antibody is consistent with a resolved hepatitis B infection of unknown duration. A result of a single hepatitis B lab study should be interpreted with caution.

 

Hepatitis B surface antibody can be measured to determine if vaccination is needed or, following a vaccination regimen, to determine if protective immunity has been achieved.

 

Samples with a concentration of 10 mIU/mL or greater are considered reactive (protective) in accordance with CDC guidelines.

Reference Range Information

Performing Location Reference Range
Marshfield

Non-Immune: NON-REACTIVE (<10.0 mIU/mL)

Immune: REACTIVE (≥10.0 mIU/mL)

Marshfield Labs Performing Department

Marshfield Labs Chemistry

Performing Information

Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
Marshfield Monday through Friday 1 day Microparticle Chemiluminometric Immunoassay/Siemens Centaur 

CPT Codes

CPT Modifier
(if needed)
Quantity Description Comments
86706        

Outreach CPT Codes

CPT Modifier
(if needed)
Quantity Description Comments
86706        

Ordering Applications

Ordering Application Description
Cerner Hepatitis B Surface Antibody